{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:22:24Z","timestamp":1780420944398,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11753-1","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:45:30Z","timestamp":1761659130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of anti-S antibody titers on newly confirmed cases of COVID-19 in Korea: a community-based cohort study (K-SEROSMART Wave 2)"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4649-0012","authenticated-orcid":false,"given":"Jina","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7715-5372","authenticated-orcid":false,"given":"Jung Ae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8900-5542","authenticated-orcid":false,"given":"Hye Jin","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9867-127X","authenticated-orcid":false,"given":"Eunbi","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9333-7682","authenticated-orcid":false,"given":"Kay O.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2923-5597","authenticated-orcid":false,"given":"June-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5610-3787","authenticated-orcid":false,"given":"Ah-Ra","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9337-8859","authenticated-orcid":false,"given":"HyeonNam","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3160-577X","authenticated-orcid":false,"given":"Soon Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1492-5253","authenticated-orcid":false,"given":"Dong-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"1","key":"11753_CR1","doi-asserted-by":"publisher","first-page":"e055515","DOI":"10.1136\/bmjopen-2021-055515","volume":"12","author":"H Baysson","year":"2022","unstructured":"Baysson H, Pennacchio F, Wisniak A, Zaballa ME, Pullen N, Collombet P, et al. Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland. BMJ Open. 2022;12(1):e055515.","journal-title":"BMJ Open"},{"issue":"1","key":"11753_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-021-11111-1","volume":"21","author":"I Ayouni","year":"2021","unstructured":"Ayouni I, Maatoug J, Dhouib W, Zammit N, Fredj SB, Ghammam R, et al. Effective public health measures to mitigate the spread of COVID-19: a systematic review. BMC Public Health. 2021;21(1):1\u201314.","journal-title":"BMC Public Health"},{"key":"#cr-split#-11753_CR3.1","unstructured":"World Health Organization. Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. World Heal Organ"},{"key":"#cr-split#-11753_CR3.2","unstructured":"2023. https:\/\/www.who.int\/news\/item\/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic."},{"issue":"9","key":"11753_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18094540","volume":"18","author":"J Korth","year":"2021","unstructured":"Korth J, Wilde B, Dolff S, Frisch J, Jahn M, Krawczyk A, et al. SARS-CoV-2 seroprevalence in healthcare workers in Germany: a follow-up study. Int J Environ Res Public Health. 2021;18(9):4540.","journal-title":"Int J Environ Res Public Health"},{"key":"11753_CR5","doi-asserted-by":"crossref","unstructured":"Radon K, Bakuli A, P\u00fctz P, Le Gleut R, Guggenbuehl Noller JM, Olbrich L, ... Fuchs C. From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany). BMC Infect Dis. 2021;21:1\u201315.","DOI":"10.1186\/s12879-021-06589-4"},{"key":"11753_CR6","doi-asserted-by":"publisher","first-page":"100371","DOI":"10.1016\/j.jvacx.2023.100371","volume":"15","author":"AA Berry","year":"2023","unstructured":"Berry AA, Tjaden AH, Renteria J, Friedman-Klabanoff D, Hinkelman AN, Gibbs MA, et al. Persistence of antibody responses to COVID-19 vaccines among participants in the COVID-19 community research partnership. Vaccine X. 2023;15:100371.","journal-title":"Vaccine X."},{"key":"11753_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2815","author":"E Mahase","year":"2020","unstructured":"Mahase E. Covid-19: what do we know about \u201clong covid\u201d? BMJ. 2020. https:\/\/doi.org\/10.1136\/bmj.m2815.","journal-title":"BMJ"},{"key":"11753_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.114646","volume":"314","author":"D Wang","year":"2022","unstructured":"Wang D, Zhao J, Zhai S, Chen H, Liu X, Fan F. Trajectories of mental health status during the early phase pandemic in China: a longitudinal study on adolescents living in the community with confirmed cases. Psychiatry Res. 2022;314:114646.","journal-title":"Psychiatry Res"},{"issue":"1","key":"11753_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12499-5","volume":"12","author":"CR Arnold","year":"2022","unstructured":"Arnold CR, Srinivasan S, Rodriguez S, Rydzak N, Herzog CM, Gontu A, et al. A longitudinal study of the impact of university student return to campus on the SARS-CoV-2 seroprevalence among the community members. Sci Rep. 2022;12(1):8586.","journal-title":"Sci Rep"},{"issue":"5","key":"11753_CR10","doi-asserted-by":"publisher","first-page":"e059869","DOI":"10.1136\/bmjopen-2021-059869","volume":"12","author":"R Madhavan","year":"2022","unstructured":"Madhavan R, Paul JS, Babji S, Kumar D, Prabhu SB, Pulleri HK, et al. Risk of COVID-19 re-infection and its predictors (CORES): protocol for a community-based longitudinal cohort study in Vellore, India. BMJ Open. 2022;12(5):e059869.","journal-title":"BMJ Open"},{"key":"11753_CR11","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2023075","author":"J Han","year":"2023","unstructured":"Han J, Baek HJ, Noh E, Yoon K, Kim JA, Ryu S, et al. Korea seroprevalence study of monitoring of SARS-COV-2 antibody retention and transmission (K-SEROSMART): findings from national representative sample. Epidemiol Health. 2023;45:e2023075. https:\/\/doi.org\/10.4178\/epih.e2023075","journal-title":"Epidemiol Health"},{"issue":"8","key":"11753_CR12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.56786\/PHWR.2023.16.8.2","volume":"16","author":"JA Kim","year":"2023","unstructured":"Kim JA, Kim IH, No JS, Lee H, Lee CY, Lee EJ, et al. Surveillance and outbreak status of SARS-CoV-2 originated from China. Public Health Weekly Report. 2023;16(8):230\u20137.","journal-title":"Public Health Weekly Report"},{"key":"11753_CR13","unstructured":"STATISTA. Cumulative monthly number of coronavirus (COVID-19) confirmed and death cases in South Korea from January 20, 2020 to July 3, 2023. Available from: https:\/\/www.statista.com\/statistics\/1098721\/south-korea-coronavirus-confirmed-and-death-number\/. Cited 2023 Dec 28."},{"key":"11753_CR14","unstructured":"STATISTA. Percentage of population in select countries and territories worldwide that had received a COVID-19 vaccination as of December 23, 2022. Available from: www.statista.com\/statistics\/1202074\/share-of-population-vaccinated-covid-19-by-county-worldwide\/. Cited 2023 Dec 28."},{"issue":"11","key":"11753_CR15","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1002\/jmv.28026","volume":"94","author":"EJ Jang","year":"2022","unstructured":"Jang EJ, Choe YJ, Yun GW, Wang S, Cho UJ, Yi S, et al. Reinfection with SARS-CoV-2 in general population, South Korea; nationwide retrospective cohort study. J Med Virol. 2022;94(11):5589\u201392.","journal-title":"J Med Virol"},{"key":"11753_CR16","first-page":"1512","volume":"16","author":"JA Shim","year":"2023","unstructured":"Shim JA, Park E, Kim RK, Lee KH, Kwon D. The suspected COVID-19 reinfection cases and vaccine effectiveness in Korea. PHWR. 2023;16:1512\u201320.","journal-title":"PHWR"},{"key":"11753_CR17","unstructured":"Korea Disease Control and Prevention Agency. Due to the suspension of the 3rd and 4th vaccinations, additional vaccinations after basic vaccination are unified as the bivalent mRNA COVID-19 vaccination. Available from: https:\/\/ncov.kdca.go.kr\/tcmBoardView.do?brdId=3&brdGubun=31&dataGubun=&ncvContSeq=7019&contSeq=7019&board_id=312&gubun=BDJ(Korean). Cited 2022 Dec 8."},{"key":"11753_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad178","author":"M Yunoki","year":"2023","unstructured":"Yunoki M, Kubota-Koketsu R, Imada T, Furuyama K, Sasaki T, Ohashi S, et al. Changes in anti\u2013SARS-CoV-2 antibody titers of pooled plasma derived from donors in Japan: a potential tool for mass-immunity evaluation. J Infect Dis. 2023;228(7):889-894. https:\/\/doi.org\/10.1093\/infdis\/jiad178","journal-title":"J Infect Dis"},{"issue":"3","key":"11753_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/infdis\/jiac403","volume":"227","author":"M Asamoah-Boaheng","year":"2023","unstructured":"Asamoah-Boaheng M, Goldfarb DM, Karim ME, O\u2019Brien SF, Wall N, Drews SJ, et al. The relationship between anti-spike SARS-CoV-2 antibody levels and risk of breakthrough COVID-19 among fully vaccinated adults. J Infect Dis. 2023;227(3):339\u201343.","journal-title":"J Infect Dis"},{"issue":"23","key":"11753_CR20","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1056\/NEJMoa2118946","volume":"386","author":"Y Goldberg","year":"2022","unstructured":"Goldberg Y, Mandel M, Bar-On YM, Bodenheimer O, Freedman LS, Ash N, et al. Protection and waning of natural and hybrid immunity to SARS-CoV-2. N Engl J Med. 2022;386(23):2201\u201312.","journal-title":"N Engl J Med"},{"issue":"5","key":"11753_CR21","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jinf.2023.07.007","volume":"87","author":"A Atti","year":"2023","unstructured":"Atti A, Insalata F, Carr EJ, Otter AD, Foulkes S, Wu MY, et al. Antibody correlates of protection against Delta infection after vaccination: a nested case-control within the UK-based SIREN study. J Infect. 2023;87(5):420\u20137.","journal-title":"J Infect"},{"key":"11753_CR22","doi-asserted-by":"crossref","unstructured":"Atti A, Insalata F, Carr EJ, Otter AD, Castillo-Olivares J, Wu M, ... Crick COVID Immunity Pipeline Consortium. Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: a nested case-control within the SIREN study. J Infect. 2022;85(5):545-556.","DOI":"10.1016\/j.jinf.2022.09.004"},{"key":"11753_CR23","doi-asserted-by":"crossref","unstructured":"Perez-Saez J, Zaballa ME, Lamour J, Yerly S, Dubos R, Courvoisier DS, ...Azman AS. Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA. 1\/BA. 2 infection. Nat Commun. 2023;14(1):3032.","DOI":"10.1101\/2022.12.13.22283400"},{"key":"11753_CR24","doi-asserted-by":"crossref","unstructured":"Yamamoto S, Oshiro Y, Inamura N, Nemoto T, Horii K, Okudera K, ... Ohmagari N. Durability and determinants of anti-SARS-CoV-2 spike antibodies following the second and third doses of mRNA COVID-19 vaccine. Clin Microbiol Infect. 2023;29(9):1201-e1 .","DOI":"10.1016\/j.cmi.2023.05.020"},{"issue":"2","key":"11753_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s40121-022-00753-2","volume":"12","author":"N Pooley","year":"2023","unstructured":"Pooley N, Abdool Karim SS, Combadi\u00e8re B, Ooi EE, Harris RC, El Guerche Seblain C, et al. Durability of vaccine-induced and natural immunity against COVID-19: a narrative review. Infect Dis Ther. 2023;12(2):367\u201387.","journal-title":"Infect Dis Ther"},{"key":"11753_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-021-01664-z","author":"A Hamady","year":"2022","unstructured":"Hamady A, Lee J, Loboda ZA. Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses? Infection. 2022;50(1):11-25. https:\/\/doi.org\/10.1007\/s15010-021-01664-z","journal-title":"Infection"},{"issue":"11","key":"11753_CR27","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3390\/vaccines9111357","volume":"9","author":"D Ferrari","year":"2021","unstructured":"Ferrari D, Clementi N, Criscuolo E, Ambrosi A, Corea F, Di Resta C, et al. Antibody titer kinetics and SARS-CoV-2 infections six months after administration with the BNT162b2 vaccine. Vaccines. 2021;9(11):1357.","journal-title":"Vaccines"},{"key":"11753_CR28","doi-asserted-by":"crossref","unstructured":"Yoon K, Kim J, Peck KR, Kim HS, Lee H, Hwang YS, ... Kim DH. Seroprevalence of severe acute respiratory syndrome coronavirus 2 antibodies during the third wave of coronavirus disease in the Seoul metropolitan area of Korea. Epidemiol Health. 2022;44:1-8.","DOI":"10.4178\/epih.e2022085"},{"issue":"5","key":"11753_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2105\/AJPH.2023.307245","volume":"113","author":"NE Dean","year":"2023","unstructured":"Dean NE, Howard DH, Lopman BA. Serological studies and the value of information. Am J Public Health. 2023;113(5):517\u20139.","journal-title":"Am J Public Health"},{"issue":"5","key":"11753_CR30","doi-asserted-by":"publisher","first-page":"514","DOI":"10.2105\/AJPH.2023.307231","volume":"113","author":"P Elliott","year":"2023","unstructured":"Elliott P, Ward H, Riley S. Population monitoring of SARS-CoV-2 infections via random sampling during the COVID-19 pandemic. Am J Public Health. 2023;113(5):514\u20136.","journal-title":"Am J Public Health"},{"issue":"5","key":"11753_CR31","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2105\/AJPH.2023.307259","volume":"113","author":"E Bendavid","year":"2023","unstructured":"Bendavid E. Seroprevalence studies are critical early pandemic tools, and they were underappreciated during COVID-19. Am J Public Health. 2023;113(5):523\u20134.","journal-title":"Am J Public Health"},{"issue":"32","key":"11753_CR32","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1016\/j.vaccine.2021.05.063","volume":"39","author":"KA Earle","year":"2021","unstructured":"Earle KA, Ambrosino DM, Fiore-Gartland A, Goldblatt D, Gilbert PB, Siber GR, et al. Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine. 2021;39(32):4423\u20138.","journal-title":"Vaccine"},{"issue":"2","key":"11753_CR33","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.vaccine.2021.12.006","volume":"40","author":"D Goldblatt","year":"2022","unstructured":"Goldblatt D, Fiore-Gartland A, Johnson M, Hunt A, Bengt C, Zavadska D, et al. Towards a population-based threshold of protection for COVID-19 vaccines. Vaccine. 2022;40(2):306\u201315.","journal-title":"Vaccine"},{"issue":"9","key":"11753_CR34","doi-asserted-by":"publisher","first-page":"e0291670","DOI":"10.1371\/journal.pone.0291670","volume":"18","author":"T Takahashi","year":"2023","unstructured":"Takahashi T, Ai T, Saito K, Nojiri S, Takahashi M, Igawa G, et al. Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccination. PLoS One. 2023;18(9):e0291670.","journal-title":"PLoS One"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11753-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11753-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11753-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T01:06:03Z","timestamp":1761699963000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11753-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11753"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11753-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of the KDCA exempted this survey from review, in accordance with Article 36 of the Bioethics Act, Article 33 of the Enforcement Rules, and Article 2 of the Bioethics Act. The study was deemed necessary for urgent public health action and was conducted directly or commissioned by the state or local government to review and evaluate public welfare or service programs (2022\u201311-02-PE-A). All participants provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1426"}}